Breaking News
February 23, 2019 - FDA Adds Boxed Warning for Increased Risk of Death with Gout Medicine Uloric (febuxostat)
February 23, 2019 - Phone-based intervention aids rheumatoid arthritis care
February 23, 2019 - Opioid epidemic makes eastern inroads and targets African-Americans
February 23, 2019 - New identified biomarker predicts patients who might benefit from HER2-targeted agents
February 23, 2019 - Study offers new insights into mechanisms of changes in erythrocytes under stress
February 23, 2019 - Antipsychotic polypharmacy may be beneficial for schizophrenia patients
February 23, 2019 - Patients with diabetes mellitus have high risk of stable ischemic heart disease
February 23, 2019 - Transparency on healthcare prices played key role in Arizona health system’s turnaround
February 23, 2019 - A comprehensive, multinational review of peppers around the world
February 23, 2019 - Study finds modest decrease in burnout among physicians
February 23, 2019 - A simple change can drastically reduce unnecessary tests for urinary tract infections
February 23, 2019 - Deep Learning-Enhanced Device Detects Diabetic Retinopathy
February 23, 2019 - Researchers discover new binding partner for amyloid precursor protein
February 23, 2019 - Modest decrease seen in burnout among physicians, researchers say | News Center
February 23, 2019 - Transplanting bone marrow of young mice into old mice prevents cognitive decline
February 23, 2019 - Mogrify to accelerate novel IP and cell therapies using $3.7m USD funding
February 23, 2019 - Johns Hopkins study describes cells that may help speed bone repair
February 23, 2019 - Scientists demonstrate influence of food odors on proteostasis
February 23, 2019 - Researchers unlock the secret behind reproduction of fish called ‘Mary’
February 23, 2019 - Acupuncture Could Help Ease Menopausal Symptoms
February 23, 2019 - Researchers use AI to detect early signs of Alzheimer’s
February 23, 2019 - On recovery, vulnerability and ritual: An exhibit in white | News Center
February 23, 2019 - Memory Stored in Unexpected Region of the Brain
February 23, 2019 - Several health experts worldwide gather at EUDONORGAN event
February 23, 2019 - Discovery of potent compound in native California shrub may lead to treatment for Alzheimer’s
February 22, 2019 - Researchers create new map of the brain’s own immune system
February 22, 2019 - ICHE’s reviews on surgical infections, unnecessary urine tests, and nurses’ role in antibiotic stewardship
February 22, 2019 - UK Research and Innovation invests £200 million to create new generation of AI leaders
February 22, 2019 - Takeda collaboration to boost fight against Alzheimer’s and other neurodegenerative diseases
February 22, 2019 - Heavy drinking may change DNA, leading to increased craving for alcohol
February 22, 2019 - U.S. opioid deaths jump fourfold in 20 years; epidemic shifts to Eastern states | News Center
February 22, 2019 - 5 Questions with William Turner on Diversity in Medicine
February 22, 2019 - HHS Finalizes Rule Seeking To Expel Planned Parenthood From Family Planning Program
February 22, 2019 - Researchers uncover biochemical pathway that may help identify drugs to treat Alzheimer’s
February 22, 2019 - Biologist uses new grant to find ways to eliminate schistosomiasis
February 22, 2019 - Bag-mask ventilation to help patients breathe during intubation prevents complications
February 22, 2019 - AbbVie Announces New Drug Application Accepted for Priority Review by FDA for Upadacitinib for Treatment of Moderate to Severe Rheumatoid Arthritis
February 22, 2019 - Nature versus nurture and addiction
February 22, 2019 - New website connects researchers with data experts, resources | News Center
February 22, 2019 - Today’s Concerns About Drug Prices Echo The Past
February 22, 2019 - CT and Doppler equipment have low accuracy in detecting cerebral vasospasm and ischemia
February 22, 2019 - Study finds out similarity in function between healthy retina cell and tumor cell
February 22, 2019 - CWRU awarded NIH grant to identify effective treatments for intimate partner violence
February 22, 2019 - Oncotype DX Not Cost-Effective for Low-Risk Breast Cancer
February 22, 2019 - Scientists discover new type of immune cells that are essential for forming heart valves
February 22, 2019 - Talk About Déjà Vu: Senators Set To Re-Enact Drug Price Hearing Of 60 Years Ago
February 22, 2019 - Genetic defect linked to pediatric liver disease identified
February 22, 2019 - New cellular atlas could provide a deeper insight into blinding diseases
February 22, 2019 - Growing number of cancer survivors, fewer providers point to challenge in meeting care needs
February 22, 2019 - Innovative compound offers a new therapeutic approach to treat multiple sclerosis
February 22, 2019 - $1.5 million grant to develop opioid treatment program for jail detainees
February 22, 2019 - FDA’s new proposed rule would update regulatory requirements for sunscreen products in the U.S
February 22, 2019 - Most Hip, Knee Replacements Last Decades, Study Finds
February 22, 2019 - Wellness problems prevalent among ob-gyn residents
February 22, 2019 - In the Spotlight: “The world is your oyster in geriatrics”
February 22, 2019 - Successful testing of multi-organ “human-on-a-chip” could replace animals as test subjects
February 22, 2019 - Analysis of cervical precancer shows decline in two strains of HPV
February 22, 2019 - Sugary stent eases suturing of blood vessels
February 22, 2019 - From surgery to psychiatry: A medical student reevaluates his motivations
February 22, 2019 - Is New App From Feds Your Answer To Navigating Medicare Coverage? Yes And No
February 22, 2019 - New pacemakers powered by heartbeats could reduce need for surgery
February 22, 2019 - The United States records highest drug overdose death rates
February 22, 2019 - Heart attacks more likely to be fatal in women and rates are rising
February 22, 2019 - Morning walks could be better than drugs at lowering blood pressure
February 22, 2019 - Phase 1 data reinforce safety profile of new drug for treating Duchenne muscular dystrophy
February 22, 2019 - Vitamin D supplementation less effective in the presence of obesity, shows study
February 22, 2019 - Novostia raises CHF 6.5 million to advance its aortic, mitral heart valve to clinical trials
February 22, 2019 - CPRIT awards nearly $20 million to The University of Texas MD Anderson Cancer Center
February 22, 2019 - Sarepta Announces FDA Acceptance of Golodirsen (SRP-4053) New Drug Application for Patients with Duchenne Muscular Dystrophy Amenable to Skipping Exon 53
February 22, 2019 - An institutional effort to reduce the amount of opioids prescribed following lumbar surgery
February 22, 2019 - Family-history-based models perform better than non-family-history based models
February 22, 2019 - Failure to take statins leads to higher mortality rates | News Center
February 22, 2019 - New study explains why some patients report phantom sensations after limb amputation
February 22, 2019 - First motor-controlled heart valves implanted by Mainz University Medical Center
February 22, 2019 - Novel preclinical model mimics persistent interneuron loss seen in preterm infants
February 22, 2019 - Global health burden of glaucoma has increased, study reveals
February 22, 2019 - A holistic approach key to minimize treatment complexity in patients with interstitial lung disease
February 22, 2019 - 1 in 10 middle-aged Chinese adults are at high risk for heart disease, finds study
February 22, 2019 - More than half a million breast cancer patient’s lives saved by improvements in treatment
February 22, 2019 - Study finds no evidence that tougher policies prevent teenage cannabis use
Low BP Associated With Risk in HFpEF

Low BP Associated With Risk in HFpEF

image_pdfDownload PDFimage_print

Action Points

  • Note that this analysis of registry data suggests an association between discharge with lower blood pressure and all-cause mortality among those with heart failure with preserved ejection fraction.
  • Be aware that the diagnosis of HFPEF may not represent a homogeneous clinical entity.

In hospitalized older people with heart failure with preserved ejection fraction (HFpEF), a systolic blood pressure level less than 120 mm Hg is independently associated with mortality and readmissions, according to a large observational study.

Systolic pressure under 120 mm Hg at discharge was associated with 2.07-fold risk (95% CI 1.45-2.95, P<0.001) of all-cause mortality within 30 days compared with higher blood pressure in matched patients, Ali Ahmed, MD, MPH, of the Veterans Affairs Medical Center in Washington, D.C., and colleagues reported online in JAMA Cardiology.

Systolic blood pressure (SBP) less than 120 mm Hg was also associated with a higher risk of mortality at 1 year (HR 1.36, 95% CI 1.16-1.59, P<0.001) and across the average follow-up of 2.1 years (HR 1.17, 95% CI 1.05-1.30, P=0.005).

A higher risk of heart failure readmission was also noted at 30 days (HR 1.47, 95% CI 1.08-2.01, P=0.02) but not at 1 year or the overall up to 6 years of follow-up. Hazard ratios for the combined endpoint of heart failure readmission or all-cause mortality associated with a low systolic level less than 120 mm Hg were:

  • At 30 days, 1.71 (95% CI 1.34-2.18 P<0.001)
  • At 1 year, 1.21 (95% CI 1.07-1.38 P=0.004)
  • Overall, 1.12 (95% CI 1.01-1.24 P=0.03)

Notably, “this association was essentially unchanged when lower SBP was defined as SBP levels less than 130 mm Hg. An SBP level less than 120 mm Hg was also associated with a significantly higher risk of the combined endpoints of heart failure readmission or mortality at all 3 times,” they wrote.

The study found no evidence of a nonlinear association between SBP and all cause mortality (P>0.20), they noted. “The association between SBP levels less than 120 mm Hg and overall all-cause mortality in our matched cohort was homogenous across various clinically relevant subgroups of patients, except those with a glomerular filtration rate less than 45 mL/min/1.73m2 and those who received a discharge prescription for ACE inhibitors.”

National guidelines for HF recommend that SBP levels should be controlled in patients with heart failure with preserved ejection fraction (HFpEF) in general, and the new 2017 blood pressure guidelines suggest an optimal target level of less than 130 mm Hg in patients with HFpEF and persistent hypertension. However, “an optimal SBP target level is less clear for patients with HFpEF,” the group noted.

“These recommendations are extrapolated from populations without heart failure because direct evidence from patients with HFpEF is limited,” they opined. “The ACE inhibitors and angiotensin II receptor blockers have been shown to modestly lower SBP levels in patients with HFpEF, but this did not translate into better outcomes.”

Ahmed’s group suggested that this and other observational studies linking lower SBP level with poor outcomes in HF patients may reflect the poorly understood phenomenon of reverse epidemiology. “Future prospective randomized clinical trials need to examine the effect of various SBP target levels on outcomes in patients with HFpEF.”

The study assessed data from the Medicare-linked Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) registry, which included more than 25,000 patients hospitalized nationwide between March 1, 2003, and Dec. 31, 2004.

Among them, 35% had an ejection fraction of at least 50%. Analysis was restricted to include the 44% of those low ejection fraction patients with stable inpatient SBP levels that varied 20 mm Hg or less from admission to discharge.

Of this cohort of almost 4,000 patients, 27% had SBP levels less than 120 mm Hg. The main analyses were on a group of 1,802 patients with higher or lower SBP who were propensity score matched on 58 baseline characteristics.

Limitations include the study’s observational nature, its potential for bias due to unmeasured confounders, and unknown generalizability to ambulatory patients with HFpEF because of differences in blood pressure determinants and measurement by setting.

While the study raised some interesting hypotheses, Willie Lawrence, MD, of the Research Medical Center in Kansas City, Missouri, echoed authors’ observations regarding the study’s lack of generalizability. He cautioned that randomized double blind studies are needed, noting that studies like SPRINT and ACCORD provide a strong basis for guideline recommendations.

As well, he noted many confounders: The diagnosis of heart failure with preserved ejection fraction is “a hodge podge of diagnoses that might include renal failure, chronic lung disease, or diastolic dysfunction for instance; heart failure is treated differently now than it was at the time of this study.”

The Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) was sponsored by GlaxoSmithKline.

Ahmed was supported by the National Institutes of Health grants from the National Heart, Lung, and Blood Institute.

Several authors disclosed relevant relationships with industry.

  • Reviewed by
    F. Perry Wilson, MD, MSCE Assistant Professor, Section of Nephrology, Yale School of Medicine and Dorothy Caputo, MA, BSN, RN, Nurse Planner

1969-12-31T19:00:00-0500

last updated

Tagged with:

About author

Related Articles